Summary:
A Randomized, Placebo-controlled, Double-blinded, Multicenter Study of
the Efficacy and Safety of a Sprinkle Formulation of Lubiprostone in Adult
Subjects with Chronic Idiopathic Constipation
Qualified Participants Must:
• Be 18 years of age or older
• Have a medically-confirmed diagnosis of chronic
constipation
Qualified Participants May Receive:
Free study medication; free physical exams; compensation per visit